Go Pro
→ Bezos… DOOMED (From Paradigm Press) (Ad)tc pixel Free UTRS Stock Alerts

Minerva Surgical (UTRS) Competitors

Minerva Surgical logo
Compare

UTRS vs. AFIB, MOTS, SSKN, DRTSW, and BDMDW

Should you buy Minerva Surgical stock or one of its competitors? Minerva Surgical's main competitors and comparable companies include Acutus Medical (AFIB), Motus GI (MOTS), Strata Skin Sciences (SSKN), Alpha Tau Medical (DRTSW), and Baird Medical Investment (BDMDW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Minerva Surgical compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and Minerva Surgical (NASDAQ:UTRS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Comparatively, 8.5% of Minerva Surgical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Minerva Surgical has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

Acutus Medical has a beta of 5.73, suggesting that its share price is 473% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.41, suggesting that its share price is 141% more volatile than the broader market.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Minerva Surgical Neutral

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Minerva Surgical N/A N/A N/A

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Minerva Surgical compare to Motus GI?

Minerva Surgical (NASDAQ:UTRS) and Motus GI (NASDAQ:MOTS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Motus GI has lower revenue, but higher earnings than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Motus GI$319K0.00-$12.87M-$14.69N/A

Minerva Surgical has a beta of 2.41, suggesting that its share price is 141% more volatile than the broader market. Comparatively, Motus GI has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

20.1% of Motus GI shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by company insiders. Comparatively, 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Motus GI Neutral

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Motus GI N/A N/A N/A

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Minerva Surgical compare to Strata Skin Sciences?

Minerva Surgical (NASDAQ:UTRS) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

Strata Skin Sciences has lower revenue, but higher earnings than Minerva Surgical. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

32.4% of Strata Skin Sciences shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Strata Skin Sciences Neutral

Given Minerva Surgical's higher probable upside, equities research analysts plainly believe Minerva Surgical is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Minerva Surgical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Minerva Surgical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Minerva Surgical's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

Minerva Surgical has a beta of 2.41, suggesting that its share price is 141% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.04, suggesting that its share price is 96% less volatile than the broader market.

Summary

Minerva Surgical beats Strata Skin Sciences on 7 of the 12 factors compared between the two stocks.

How does Minerva Surgical compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Minerva Surgical (NASDAQ:UTRS) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

Alpha Tau Medical has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

In the previous week, Alpha Tau Medical had 2 more articles in the media than Minerva Surgical. MarketBeat recorded 2 mentions for Alpha Tau Medical and 0 mentions for Minerva Surgical. Minerva Surgical's average media sentiment score of 0.00 beat Alpha Tau Medical's score of -1.32 indicating that Minerva Surgical is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Negative
Minerva Surgical Neutral

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Minerva Surgical N/A N/A N/A

Summary

Minerva Surgical beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks.

How does Minerva Surgical compare to Baird Medical Investment?

Minerva Surgical (NASDAQ:UTRS) and Baird Medical Investment (NASDAQ:BDMDW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Baird Medical Investment N/A N/A N/A

Baird Medical Investment has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Baird Medical Investment$22.54MN/AN/AN/AN/A

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Baird Medical Investment'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Baird Medical Investment Neutral

Summary

Minerva Surgical beats Baird Medical Investment on 1 of the 1 factors compared between the two stocks.

Get Minerva Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UTRS vs. The Competition

Export
MetricMinerva SurgicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1K$5.81B$7.26B$12.73B
Dividend YieldN/A1.76%2.53%8.86%
P/E Ratio0.0025.92273.2925.38
Price / SalesN/A73.28613.4597.56
Price / CashN/A33.1477.8252.26
Price / BookN/A6.0412.896.14
Net Income-$34.11M$150.03M$3.47B$349.01M

Minerva Surgical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
AFIB
Acutus Medical
N/AN/AN/A-83.3%$3K$7.16MN/A340
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
SSKN
Strata Skin Sciences
N/A$0.00
flat		N/A-99.7%$1K$30.98MN/A120
DRTSW
Alpha Tau Medical
N/A$4.00
-5.7%		N/A+1,290.1%$0.00N/AN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:UTRS) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
In 1984, a 10000 dollar stake in Apple could have grown to 25 million dollars for early investors who simply g...
Eagle Publishing | Sponsoredtc pixel